MEDP vs PCAR · P/E 25, rev $707.3M vs P/E 25, rev $33.66B
Medpace Holdings Inc (MEDP) versus PACCAR Inc (PCAR) — a side-by-side from cached financials, not a winner call.
Medpace Holdings Inc (MEDP) is a diagnostics & research company listed on US.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Latest reported MEDP revenue for 2026-06-30 was $707.3M. Net income was $121.4M. Revenue was up 0.1% from 2026-03-31 to 2026-06-30. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
MEDP currently screens at market cap $9.30B and trailing P/E 24.7. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Not investment advice. Open the MEDP and PCAR stock pages for the full models.
Not investment advice.